OpenURL Connection Search

Select item for more details and to access through your institution.

The prevalence of right-sided colonic diverticulosis and diverticular haemorrhage.
Published in:
Colorectal Disease, 2013, v. 15, n. 5, p. e266, doi. 10.1111/codi.12137
By:
- Faucheron, J.‐L.;
- Roblin, X.;
- Bichard, P.;
- Heluwaert, F.
Publication type:
Article
Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis.
Published in:
Digestive Diseases & Sciences, 2022, v. 67, n. 6, p. 2492, doi. 10.1007/s10620-021-07074-3
By:
- Servais, L.;
- Boschetti, G.;
- Meunier, C.;
- Gay, C.;
- Cotte, E.;
- François, Y.;
- Rozieres, A.;
- Fontaine, J.;
- Cuminal, L.;
- Chauvenet, M.;
- Charlois, A. L.;
- Isaac, S.;
- Traverse-Glehen, A.;
- Roblin, X.;
- Flourié, B.;
- Valette, P. J.;
- Nancey, S.
Publication type:
Article
Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn’s disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2007, v. 25, n. 7, p. 797, doi. 10.1111/j.1365-2036.2007.03260.x
By:
- ROBLIN, X.;
- PHELIP, J. M.;
- GENEVOIS, M.;
- DUCROS, V.;
- BONAZ, B.
Publication type:
Article
6-Tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 7, p. 829, doi. 10.1111/j.1365-2036.2005.02419.x
By:
- Roblin, X.;
- Serre‐Debeauvais, F.;
- Phelip, J.‐M.;
- Faucheron, J.‐L.;
- Hardy, G.;
- Chartier, A.;
- Helluwaert, F.;
- Bessard, G.;
- Bonaz, B.
Publication type:
Article
Drug interaction between infliximab and azathioprine in patients with Crohn's disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 9, p. 917, doi. 10.1046/j.1365-2036.2003.01778.x
By:
- Roblin, X.;
- Serre‐Debeauvais, F.;
- Phelip, J.‐M.;
- Bessard, G.;
- Bonaz, B.
Publication type:
Article
Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature.
Published in:
2017
By:
- Venturin, C.;
- Nancey, S.;
- Danion, P.;
- Uzzan, M.;
- Chauvenet, M.;
- Bergoin, C.;
- Roblin, X.;
- Flourié, B.;
- Boschetti, G.
Publication type:
journal article
Letter: new thresholds need to be defined when using point of care assays to monitor infliximab trough levels in IBD patients.
Published in:
2018
By:
- Dutzer, D.;
- Nasser, Y.;
- Berger, A. E.;
- Roblin, X.;
- Paul, S.
Publication type:
Letter to the Editor
Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti‐tumour necrosis factor.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 8, p. 1117, doi. 10.1111/apt.14567
By:
- Ben‐Horin, S.;
- Ungar, B.;
- Kopylov, U.;
- Lahat, A.;
- Yavzori, M.;
- Fudim, E.;
- Picard, O.;
- Peled, Y.;
- Eliakim, R.;
- Del Tedesco, E.;
- Paul, S.;
- Roblin, X.
Publication type:
Article
Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 7, p. 906, doi. 10.1111/apt.14548
By:
- Yacoub, W.;
- Williet, N.;
- Pouillon, L.;
- Di‐Bernado, T.;
- De Carvalho Bittencourt, M.;
- Nancey, S.;
- Lopez, A.;
- Paul, S.;
- Zallot, C.;
- Roblin, X.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 588, doi. 10.1111/apt.14487
By:
- Wils, P.;
- Bouhnik, Y.;
- Michetti, P.;
- Flourie, B.;
- Brixi, H.;
- Bourrier, A.;
- Allez, M.;
- Duclos, B.;
- Serrero, M.;
- Buisson, A.;
- Amiot, A.;
- Fumery, M.;
- Roblin, X.;
- Peyrin‐Biroulet, L.;
- Filippi, J.;
- Bouguen, G.;
- Abitbol, V.;
- Coffin, B.;
- Simon, M.;
- Laharie, D.
Publication type:
Article
Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 485, doi. 10.1111/apt.14419
By:
- Tadbiri, S.;
- Peyrin‐Biroulet, L.;
- Serrero, M.;
- Filippi, J.;
- Pariente, B.;
- Roblin, X.;
- Buisson, A.;
- Stefanescu, C.;
- Trang‐Poisson, C.;
- Altwegg, R.;
- Marteau, P.;
- Vaysse, T.;
- Bourrier, A.;
- Nancey, S.;
- Laharie, D.;
- Allez, M.;
- Savoye, G.;
- Gilletta, C.;
- Gagniere, C.;
- Vuitton, L.
Publication type:
Article
Letter: thiopurines - is less really more? Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 1, p. 150, doi. 10.1111/apt.14385
By:
- Roblin, X.;
- Paul, S.;
- Nancey, S.;
- Flourie, B.
Publication type:
Article
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 3, p. 310, doi. 10.1111/apt.14167
By:
- Amiot, A.;
- Serrero, M.;
- Peyrin‐Biroulet, L.;
- Filippi, J.;
- Pariente, B.;
- Roblin, X.;
- Buisson, A.;
- Stefanescu, C.;
- Trang‐Poisson, C.;
- Altwegg, R.;
- Marteau, P.;
- Vaysse, T.;
- Bourrier, A.;
- Nancey, S.;
- Laharie, D.;
- Allez, M.;
- Savoye, G.;
- Moreau, J.;
- Vuitton, L.;
- Viennot, S.
Publication type:
Article
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 2, p. 142, doi. 10.1111/apt.14106
By:
- Roblin, X.;
- Boschetti, G.;
- Williet, N.;
- Nancey, S.;
- Marotte, H.;
- Berger, A.;
- Phelip, J. M.;
- Peyrin‐Biroulet, L.;
- Colombel, J. F.;
- Del Tedesco, E.;
- Paul, S.;
- Flourie, B.
Publication type:
Article
Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 5, p. 760, doi. 10.1111/apt.13932
By:
- Ben-Horin, S.;
- Ungar, B.;
- Roblin, X.
Publication type:
Article
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 2, p. 276, doi. 10.1111/apt.13862
By:
- Ungar, B.;
- Kopylov, U.;
- Engel, T.;
- Yavzori, M.;
- Fudim, E.;
- Picard, O.;
- Lang, A.;
- Williet, N.;
- Paul, S.;
- Chowers, Y.;
- Bar‐Gil Shitrit, A.;
- Eliakim, R.;
- Ben‐Horin, S.;
- Roblin, X.
Publication type:
Article
Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 7, p. 939, doi. 10.1111/apt.13335
By:
- Paul, S.;
- Roblin, X.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 3, p. 356, doi. 10.1111/apt.13268
By:
- Ben‐Horin, S.;
- Chowers, Y.;
- Ungar, B.;
- Kopylov, U.;
- Loebstein, R.;
- Weiss, B.;
- Eliakim, R.;
- Del Tedesco, E.;
- Paul, S.;
- Roblin, X.
Publication type:
Article
Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 2, p. 240, doi. 10.1111/apt.13238
By:
- Roblin, X.;
- Paul, S.
Publication type:
Article
Factors associated with pregnancy outcome in anti- TNF treated women with inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 4, p. 363, doi. 10.1111/apt.12833
By:
- Seirafi, M.;
- Vroey, B.;
- Amiot, A.;
- Seksik, P.;
- Roblin, X.;
- Allez, M.;
- Peyrin‐Biroulet, L.;
- Marteau, P.;
- Cadiot, G.;
- Laharie, D.;
- Boureille, A.;
- De Vos, M.;
- Savoye, G.;
- Rahier, J.‐F.;
- Carbonnel, F.;
- Bonaz, B.;
- Colombel, J.‐F.;
- Bouhnik, Y.
Publication type:
Article
The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 7, p. 712, doi. 10.1111/apt.12650
By:
- Delvincourt, M.;
- Lopez, A.;
- Pillet, S.;
- Bourrier, A.;
- Seksik, P.;
- Cosnes, J.;
- Carrat, F.;
- Gozlan, J.;
- Beaugerie, L.;
- Roblin, X.;
- Peyrin‐Biroulet, L.;
- Sokol, H.
Publication type:
Article
Review article: biosimilars are the next generation of drugs for liver and gastrointestinal diseases.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 8, p. 914, doi. 10.1111/apt.12477
By:
- Rinaudo‐Gaujous, M.;
- Paul, S.;
- Tedesco, E. D.;
- Genin, C.;
- Roblin, X.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Letter: extracorporeal photopheresis in refractory chronic active ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 4, p. 443, doi. 10.1111/apt.12394
By:
- Nancey, S.;
- Boschetti, G.;
- Moussata, D.;
- Hequet, O.;
- Roblin, X.;
- Flourié, B.
Publication type:
Article
Letter: mucosal healing in ulcerative colitis - higher relevance than in Crohn's disease? Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 2, p. 208, doi. 10.1111/apt.12361
By:
- Laharie, D.;
- Filippi, J.;
- Roblin, X.;
- Nancey, S.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 10, p. 998, doi. 10.1111/apt.12289
By:
- Laharie, D.;
- Filippi, J.;
- Roblin, X.;
- Nancey, S.;
- Chevaux, J.‐B.;
- Hébuterne, X.;
- Flourié, B.;
- Capdepont, M.;
- Peyrin‐Biroulet, L.
Publication type:
Article
Letter: TPMT activity and age in IBD patients - authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 8, p. 967, doi. 10.1111/j.1365-2036.2012.05052.x
By:
- Chouchana, L.;
- Narjoz, C.;
- Beaune, P.;
- Loriot, M.‐A.;
- Roblin, X.
Publication type:
Article
Letter: thiopurine blood monitoring for patients with inflammatory bowel disease - authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 6, p. 743, doi. 10.1111/j.1365-2036.2012.05003.x
By:
- Chouchana, L.;
- Narjoz, C.;
- Beaune, P.;
- Loriot, M.‐A.;
- Roblin, X.
Publication type:
Article
Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 1, p. 15, doi. 10.1111/j.1365-2036.2011.04905.x
By:
- Chouchana, L.;
- Narjoz, C.;
- Beaune, P.;
- Loriot, M.‐A.;
- Roblin, X.
Publication type:
Article
Appendicectomy as a potential therapy for refractory ulcerative proctitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 2, p. 257, doi. 10.1111/j.1365-2036.2011.04705.x
By:
- Bageacu, S.;
- Coatmeur, O.;
- Lemaitre, J. P.;
- Lointier, P.;
- Del tedesco, E.;
- Phelip, J. M.;
- Roblin, X.
Publication type:
Article
The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 6, p. 707, doi. 10.1111/j.1365-2036.2011.04577.x
By:
- Peyrin‐Biroulet, L.;
- Oussalah, A.;
- Roblin, X.;
- Sparrow, M. P.
Publication type:
Article
Infliximab for refractory ulcerative proctitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 11, p. 1178, doi. 10.1111/j.1365-2036.2010.04293.x
By:
- BOUGUEN, G.;
- ROBLIN, X.;
- BOURREILLE, A.;
- FEIER, L.;
- FILIPPI, J.;
- NANCEY, S.;
- BRETAGNE, J.‐F.;
- FLOURIÉ, B.;
- HÉBUTERNE, X.;
- BIGARD, M.‐A.;
- SIPROUDHIS, L.;
- PEYRIN‐BIROULET, L.
Publication type:
Article
Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey.
Published in:
Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 8, p. 854, doi. 10.1111/j.1365-2036.2009.04097.x
By:
- OUSSALAH, A.;
- ROBLIN, X.;
- LAHARIE, D.;
- FILIPPI, J.;
- FLAMANT, M.;
- FAURE, P.;
- PHELIP, J.‐M.;
- BIGARD, M.‐A.;
- PEYRIN‐BIROULET, L.
Publication type:
Article
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression.
Published in:
Alimentary Pharmacology & Therapeutics, 2008, v. 28, n. 8, p. 984, doi. 10.1111/j.1365-2036.2008.03812.x
By:
- PEYRIN‐BIROULET, L.;
- CADRANEL, J.‐F.;
- NOUSBAUM, J.‐B.;
- OUSSALAH, A.;
- SEDDIK, M.;
- CANVA, V.;
- CORTOT, A.;
- SOGNI, P.;
- GUEANT, J.‐L;
- BIGARD, M.‐A.;
- ROBLIN, X.;
- BRONOWICKI, J.‐P.
Publication type:
Article
Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience.
Published in:
Alimentary Pharmacology & Therapeutics, 2008, v. 28, n. 8, p. 966, doi. 10.1111/j.1365-2036.2008.03811.x
By:
- OUSSALAH, A.;
- LACLOTTE, C.;
- CHEVAUX, J.‐B.;
- BENSENANE, M.;
- BABOURI, A.;
- SERRE, A.‐A.;
- BOUCEKKINE, T.;
- ROBLIN, X.;
- BIGARD, M.‐A.;
- PEYRIN‐BIROULET, L.
Publication type:
Article
How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study.
Published in:
Journal of Crohn's & Colitis, 2022, v. 16, n. 8, p. 1202, doi. 10.1093/ecco-jcc/jjac035
By:
- Cottron, C;
- Treton, X;
- Altwegg, R;
- Reenaers, C;
- Amiot, A;
- Fumery, M;
- Vuitton, L;
- Peyrin-Biroulet, L;
- Bouguen, G;
- Dewit, O;
- Nancey, S;
- Caillo, L;
- Roblin, X;
- Beylot-Barry, M;
- Rivière, P;
- Laharie, D
Publication type:
Article
Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE].
Published in:
Journal of Crohn's & Colitis, 2021, v. 15, n. 3, p. 432, doi. 10.1093/ecco-jcc/jjaa195
By:
- Moreau, J;
- Hammoudi, N;
- Marthey, L;
- Trang-Poisson, C;
- Nachury, M;
- Altwegg, R;
- Grimaud, J C;
- Orempuller, S;
- Hébuterne, X;
- Aubourg, A;
- Baudry, C;
- Seksik, P;
- Roblin, X;
- Nahon, S;
- Savoye, G;
- Mesnard, B;
- Stefanescu, C;
- Simon, M;
- Coffin, B;
- Fumery, M
Publication type:
Article
Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease.
Published in:
Journal of Crohn's & Colitis, 2015, v. 9, n. 7, p. 252, doi. 10.1093/ecco-jcc/jjv061
By:
- Roblin, X.;
- Marotte, H.;
- Leclerc, M.;
- Del Tedesco, E.;
- Phelip, J. M.;
- Peyrin-Biroulet, L.;
- Paul, S.
Publication type:
Article
Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Published in:
Journal of Crohn's & Colitis, 2015, v. 9, n. 6, p. 445, doi. 10.1093/ecco-jcc/jjv063
By:
- Paul, S.;
- Boschetti, G.;
- Rinaudo-Gaujous, M.;
- Moreau, A.;
- Del Tedesco, E.;
- Bonneau, J.;
- Presles, E.;
- Mounsef, F.;
- Clavel, L.;
- Genin, C.;
- Flourié, B.;
- Phelip, J.-M.;
- Nancey, S.;
- Roblin, X.
Publication type:
Article
Efficacy of Sustained Combination Therapy for at Least 6 Months with Thiopurines and Infliximab in Patients with Ulcerative Colitis in Clinical Remission: A Retrospective Multicenter French Experience.
Published in:
Journal of Crohn's & Colitis, 2015, v. 9, n. 3, p. 252, doi. 10.1093/ecco-jcc/jjv001
By:
- Filippi, J.;
- Laharie, D.;
- Michiels, C.;
- Flamand, M.;
- Bouguen, G.;
- Nancey, S.;
- Presles, E.;
- Paul, S.;
- Schneider, S.;
- Hébuterne, X.;
- Roblin, X.
Publication type:
Article
Management of perianal fistulas in Crohn's disease: a 2021 update of the French National Society of Coloproctology consensus.
Published in:
Techniques in Coloproctology, 2022, v. 26, n. 10, p. 805, doi. 10.1007/s10151-022-02678-x
By:
- Bouchard, D.;
- Pigot, F.;
- de Parades, V.;
- Staumont, G.;
- Abramowitz, L.;
- Siproudhis, L.;
- Members of the SNFCP;
- Tracanelli, L.;
- Fathallah, N.;
- Babin-Pigot, E.;
- Ferry, M.;
- Members of the GETAID;
- Bouguen, G.;
- Laharie, D.;
- Cotte, E.;
- Panis, Y.;
- Peyrin-Biroulet, L.;
- Roblin, X.;
- Zerbib, P.
Publication type:
Article
Kinetics of Antibodies Against Adalimumab Are Not Associated With Poor Outcomes in IBD.
Published in:
American Journal of Gastroenterology (Springer Nature), 2015, v. 110, n. 5, p. 777, doi. 10.1038/ajg.2015.79
By:
- Paul, S;
- Dronne, W;
- Roblin, X
Publication type:
Article
Response to Bodini et al.
Published in:
American Journal of Gastroenterology (Springer Nature), 2015, v. 110, n. 3, p. 473, doi. 10.1038/ajg.2015.12
By:
- Paul, S;
- Roblin, X
Publication type:
Article

Found: 42